BIS revenue rises but profit falls


Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...

Sign in  as a member, or Join our Community  for free to unlock the full article.

Joint-Editor, Asian Meat Magazine and Meat Insider, Bangkok, Thailand. Writes on how high inflation and raw material costs challenges in Thailand are not a deterrent for the plant-based protein market in ‘Taste, flavor and nutrition important for plant-based protein’.